Skip to main content
SpringerLink
Log in

Œdème maculaire cystoïde dans les uvéites

  • Chapter
Œdèmes maculaires

  • 232 Accesses

Résumé

L’œdème maculaire est une cause majeure de morbidité chez les patients atteints d’uvéites. Les médiateurs de l’inflammation agissent sur l’intégrité de barrière hémato-oculaire et sur la fonction de pompe de l’épithélium pigmentaire. La chronicité de l’œdème entraîne des altérations irréversibles et semble être la cause de plus de 30 % des cas de baisse permanente d’acuité visuelle chez les patients atteints d’uvé

Reconnaître la présence et la sévérité de l’œdème grace à l’utilisation des diverses techniques les plus appropriées d’investigation (Spectral Domain-OCT et angiographie) a permis de déterminer les possibilités de réversibilité et de définir une stratégie thérapeutique au sein de laquelle les stéroïdes intraoculaires jouent un rôle majeur alors que les indications des stimulateurs de la pompe de l’épithélium pigmentaire et de la chirurgie sont limitées à des affections plus sévères ou à la présence de syndrome de traction

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Pournaras CJ, Rungger-Brändle E, Riva CE, et al. (2008) Regulation of retinal blood flow in health and disease. Progress in Retinal and Eye Research 27: 284–330

    Article  PubMed  CAS  Google Scholar 

  2. Foster CS, Fong LP, Singh G (1989) Cataract surgery and intraocular lens implantation in patients with uveitis. Ophthalmol 96: 281–288

    CAS  Google Scholar 

  3. Rothova A, Suttorp-van Schulten MSA, Terffers WF, Kijlstra A (1996) Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80: 332–336

    Article  PubMed  CAS  Google Scholar 

  4. Rothova A (2007) Inflammatory cystoid macular edema. Current Opinion in Ophthalmology 18: 487–492

    Article  PubMed  Google Scholar 

  5. Lardenoye CWTA, van Kooij B, Rothova A (2006) Impact of Macular Edema on Visual Acuity in Uveitis. Ophthalmol 113: 1446–1449

    Article  Google Scholar 

  6. de Boer J, Wulffraat N, Rothova A (2003) Visual loss in uveitis of childhood. Br J Ophthalmol 87: 879–884

    Article  PubMed  Google Scholar 

  7. Smith JA, Mackensen F, Sen HN, et al. (2009) Epidemiology and course of diease in childhood uveitis. Ophthalmol 116: 1544–1551

    Article  Google Scholar 

  8. Monnet D, Levinson RD, Holland GN, et al. (2007) Longitudinal Cohort Study of Patients with Birdshot Chorioretinopathy. III. Macular Imaging at Baseline. Am J Ophthalmol 144: 818–828

    Article  PubMed  Google Scholar 

  9. Johnson MW (2009) Etiology and Treatment of Macular Edema. Am J Ophthalmol 147: 11–21

    Article  PubMed  Google Scholar 

  10. Kiss CG, Barisani-Asenbauer T, Maca S, et al. (2006) Reading Performance of Patients with Uveitis-Associated Cystoid Macular Edema. Am J Ophthalmol 142: 620–624.e1

    Article  PubMed  Google Scholar 

  11. Hazel A, Petre K, Armstrong RA (2000) Visual function and subjective quality of life compared in subjects with acquired macular disease. Invest Ophthalmol Vis Sci 41: 1309–1315

    PubMed  CAS  Google Scholar 

  12. Markomichelakis NN, Halkiadais I, Pantelia E, et al. (2005) Patterns of macular edema in patients with uveitis. Qualitative and quantitative assessment using optical coherence tomography. Ophthalmol 111: 946–953

    Article  Google Scholar 

  13. Catier A, Tadayoni R, Paques M, et al. (2005) Characterization of macular edema from various etiologies by optical coherence tomography. Am J Ophthalmol 140: 200–206

    Article  PubMed  Google Scholar 

  14. Tran THC, de Smet MD, Bodaghi B, et al. (2008) Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography. Br J Ophthalmol 92: 922–927

    Article  PubMed  CAS  Google Scholar 

  15. Acharya NR, Hong KC, Lee SM (2009) Ranibizumab for Refractory Uveitis-related Macular Edema. Am J Ophthalmol 148: 303–309

    Article  PubMed  CAS  Google Scholar 

  16. Markomichelakis NN, Theodossiadis PG, Sfikakis PP (2005) Regression of neovascular age-related macular degeneration following infliximab therapy. Am J Ophthalmol 139: 537–540

    Article  PubMed  Google Scholar 

  17. van Kooij B, Rothova A, Rijkers GT, de Groot-Mijnes JDF (2006) Distinct Cytokine and Chemokine Profiles in the Aqueous of Patients With Uveitis and Cystoid Macular Edema. Am J Ophthalmol 142: 192–194

    Article  PubMed  Google Scholar 

  18. Probst K, Fijnheer R, Rothova A (2004) Endothelial cell activation and hypercoagulability in ocular Behçet’s disease. Am J Ophthalmol 137: 850–857

    Article  PubMed  CAS  Google Scholar 

  19. Curnow SJ, Falciani F, Durrani OM, et al. (2005) Multiplex Bead Immunoassay Analysis of Aqueous Humor Reveals Distinct Cytokine Profiles In Uveitis. Investigative Ophthalmology Visual Science 46: 4251–4259

    Article  PubMed  Google Scholar 

  20. Leal E, Manivannan A, Hosoya K, et al. (2007) Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-reinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci 48: 5257–5265

    Article  PubMed  Google Scholar 

  21. van Kooij B, Fijnheer R, Roest M, Rothova A (2004) Trace microalbuminuria in inflammatory cystoid macular edema. Am J Ophthalmol 138: 1010–1015

    Article  PubMed  Google Scholar 

  22. Lin P, Loh AR, Margolis TP, et al. (2010) Cigarette smoking as a risk factor for uveitis. Ophthalmol 117: 585–590

    Article  Google Scholar 

  23. Thorne JE, Daniel E, Jabs DA, et al. (2008) Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis. Am J Ophthalmol 145: 841–846

    Article  PubMed  Google Scholar 

  24. Kaercher Kramer C, de Azevedo MJ, da Costa Rodrigues T, et al. (2008) Smoking habit is associated with diabetic macular edema in type I diabetes mellitus patients. Journal of Diabetes and its Complications 22: 430

    Article  Google Scholar 

  25. Pruett R, Brockhurst RJ, Letts N (1974) Fluorescein angiography of peripheral uveitis. Am J Ophthalmol 77: 448–453

    PubMed  CAS  Google Scholar 

  26. van Kooij B, Probst K, Fijnheer R, et al. (2008) Risk factors for cystoid macular oedema in patients with uveitis. Eye 22: 256–260

    Article  PubMed  Google Scholar 

  27. Markomichelakis NN, Halkiadais I, Pantelia E, et al. (2005) Patterns of Macular Edema in Patients with Uveitis. Qualitative and Quantitative Assessment Using Optical Coherence Tomography. Ophthalmol 111: 946–953

    Article  Google Scholar 

  28. Forooghian F, Yeh S, Faia LJ, Nussenblatt RB (2009) Uveitis foveal atrophy. Arch Ophthalmol 127: 179–186

    Article  PubMed  Google Scholar 

  29. Gürlü VP, Alimgil ML, Esgin H (2007) Fluorescein angiographic findings in cases with intermediate uveitis in the inactive phase. Can J Ophthalmol 42: 107–109

    PubMed  Google Scholar 

  30. Tugal-Tutkun I, Herbort CP, Kharairallah M (2008) (ASUWOG) TASfUWG. Scoring of dual fluorescein and ICG inflammatory angiographic igns for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis). Int Ophthalmol; Eprint

    Google Scholar 

  31. Nussenblatt RB, Kaufman SC, Palestine AG, et al. (1987) Macular thickening and visual acuity. Measurement in patients with cystoid macular edema. Ophthalmol 94: 1134–1139

    CAS  Google Scholar 

  32. Kiernan DF, Hariprasad SM, Chin EK, et al. (2009) Prospective Comparison of Cirrus and Stratus Optical Coherence Tomography for Quantifying Retinal Thickness. Am J Ophthalmol 147: 267–275

    Article  PubMed  Google Scholar 

  33. Roesel M, Henschel A, Heinz C, et al. (2009) Fundus autofluorescence and spectral domain optical coherence tomography in uveitis macular edema. Graefe’s Arch Clin Exp Ophthalmol; on line

    Google Scholar 

  34. Vujosevic S, Midena E, Pilotto E, et al. (2006) Diabetic Macular Edema: Correlation between Microperimetry and Optical Coherence Tomography Findings. Invest Ophthalmol Vis Sci 47: 3044–3051

    Article  PubMed  Google Scholar 

  35. Jabs DA, Rosenbaum JT (2001) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 131: 679

    Article  PubMed  CAS  Google Scholar 

  36. Mochizuki M, de Smet MD (1994) Use of immunosuppressive agents in ocular diseases. Prog Ret Eye Res 13: 479–506

    Article  CAS  Google Scholar 

  37. Rhen T, Cidlowski JA (2005) Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs. N Engl J Med 353: 1711–1723

    Article  PubMed  CAS  Google Scholar 

  38. Venkatesh P, Abhas Z, Garg S, Vohra R (2007) Prospective optical coherence tomographic evaluation of the efficacy of oral and posterior subtenon corticosteroids in patients with intermediate uveitis. Graefe’s Archive for Clinical and Experimental Ophthalmology 245: 59–67

    Article  PubMed  CAS  Google Scholar 

  39. Markomichelakis NN, Theodossiadis PG, Pantalia E, et al. (2004) Infliximab for chronic cystoid macular edema associated with uveitis. Am J Ophthalmol 138: 648–650

    Article  PubMed  CAS  Google Scholar 

  40. Hale S, Lightman S (2006) Anti-TNF therapies in the management of acute and chronic uveitis. Cytokine 33: 231–237

    Article  PubMed  CAS  Google Scholar 

  41. Kötter I, Gunaydin I, Zierhut M, Stübiger N (2004) The use of interferon a in Behcet disease: review of the literature. Semin Arthritis Rheum 33: 320–325

    Article  PubMed  Google Scholar 

  42. Kötter I, Eckstein AK, Stübiger N, Zierhut M (1998) Treatment of ocular symptoms of Behçet’s disease with interferon a2a: a pilot study. Br J Ophthalmol 82: 488–489.

    Article  PubMed  Google Scholar 

  43. Tugal-Tutkun I, Güney-Tefekli E, Urgancioglu M (2006) Results of interferon-alfa therapy in patients with Behçet uveitis. Graefe’s Arch Clin Exp Ophthalmol 244: 1692–1695

    Article  CAS  Google Scholar 

  44. Deuter CME, Koetter I, Ouenaydin I, et al. (2006) Interferon alfa-2A: a new treatment option for long lasting refractory cystoid macular edema in uveitis? Retina 26: 786–791

    Article  PubMed  Google Scholar 

  45. Bodaghi B, Gendron G, Wechsler B, et al. (2007) Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients. Br J Ophthalmol 91: 335–359

    Article  PubMed  Google Scholar 

  46. Plskova J, Greiner K, Forrester JV (2007) Interferon-[alpha] as an Effective Treatment for Noninfectious Posterior Uveitis and Panuveitis. Am J Ophthalmol 144: 55–61

    Article  PubMed  CAS  Google Scholar 

  47. Cunningham MA, Edelman JL, Kaushal S (2008) Intravitreal Steroids for Macular Edema: The Past, the Present, and the Future. Surv Ophthalmol 53: 139–149

    Article  PubMed  Google Scholar 

  48. Sallam A, Comer RM, Chang JH, et al. (2008) Shortterm Safety and Efficacy of Intravitreal Triamcinolone Acetonide for Uveitic Macular Edema in Children. Arch Ophthalmol 126: 200–205

    Article  PubMed  Google Scholar 

  49. Okada K, Wakabayashi T, Morimura Y, et al. (2003) Trans-tenon’s retrobulbar triamcinolone infusion for the treatment of uveitis. Brit J Ophthalmol 87: 1–4

    Article  Google Scholar 

  50. Schindler RH, Chandler D, Thresher R, Machemer R (1982) The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol 93: 415–417

    PubMed  CAS  Google Scholar 

  51. Beer PM, Bakri SJ, Singh RJ, et al. (2003) Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmol 110: 681–686

    Article  Google Scholar 

  52. Kok H, Lau C, Maycock N, et al. (2005) Outcome of Intravitreal Triamcinolone in Uveitis. Ophthalmol 112: 1916

    Article  Google Scholar 

  53. Yamamoto Y, Komatsu T, Koura Y, et al. (2008) Intraocular pressure elevation after intravitreal or posterior sub-tenon triamcinolone acetonide injection. Can J Ophthalmol 43: 42–47

    Article  PubMed  Google Scholar 

  54. Maca SM, Abela-Formanek C, Kiss CG, et al. (2009) Intravitreal triamcinolone for persistent cystoid macular oedema in eyes with quiescent uveitis. Clinical and Experimental Ophthalmology 37: 389–396

    Article  PubMed  Google Scholar 

  55. Sallam A, Sheth HG, Habot-Wilner Z, Lightman S (2009) Outcome of Raised Intraocular Pressure in Uveitic Eyes with and without a Corticosteroid-Induced Hypertensive Response. Am J Ophthalmol 148: 207–213

    Article  PubMed  Google Scholar 

  56. Inatani M, Iwao K, Kawaji T, et al. (2008) Intraocular Pressure Elevation after Injection of Triamcinolone Acetonide: A Multicenter Retrospective Case-Control Study. Am J Ophthalmol 145: 676–681

    Article  PubMed  CAS  Google Scholar 

  57. Scott IU, Flynn HW, Jr (2007) Reducing the risk of endophthalmitis following intravitreal injections. Retina 27: 10–12

    Article  PubMed  Google Scholar 

  58. Bhavsar AR, Googe JM, Jr, Stockdale CR, et al. (2009) Risk of Endophthalmitis After Intravitreal Drug Injection When Topical Antibiotics Are Not Required: The Diabetic Retinopathy Clinical Research Network Laser-Ranibizumab-Triamcinolone Clinical Trials. Arch Ophthalmol 127: 1581–1583

    Article  PubMed  CAS  Google Scholar 

  59. Bhavsar AR, Ip MS, Glassman AR (2007) The Risk of Endophthalmitis Following Intravitreal Triamcinolone Injection in the DRCRnet and SCORE Clinical Trials. Am J Ophthalmol 144: 454–456

    Article  PubMed  CAS  Google Scholar 

  60. Chen SDM, Lochhead J, McDonald B, Patel CK (2004) Pseudohypopyon after intravitreal triamcinolone injection for the treatment of pseudophakic cystoid macular oedema. Br J Ophthalmol 88: 843–844

    Article  PubMed  CAS  Google Scholar 

  61. Byun YS, Park Y-H (2009) Complications and Safety Profile of Posterior Subtenon Injection of Triamcinolone Acetonide. Journal of Ocular Pharmacology and Therapeutics 25: 159–162

    Article  PubMed  CAS  Google Scholar 

  62. Thomas ER, Wang J, Ege E, et al. (2006) Intravitreal Triamcinolone Acetonide Concentration After Subtenon Injection. Am J Ophthalmol 142: 860–861

    Article  PubMed  CAS  Google Scholar 

  63. Nozik RA (1972) Periocular injection of steroids. Trans Am Acad Ophthalmol Otolaryngol 76: 695–705

    PubMed  CAS  Google Scholar 

  64. Narayanan R, Mungcal JK, Kenney MC, et al. (2006) Toxicity of Triamcinolone Acetonide on Retinal Neurosensory and Pigment Epithelial Cells. Invest Ophthalmol Vis Sci 47: 722–728

    Article  PubMed  Google Scholar 

  65. Chung H, Hwang JJ, Koh JY, et al. (2007) Triamcinolone Acetonide-Mediated Oxidative Injury in Retinal Cell Culture: Comparison with Dexamethasone. Invest Ophthalmol Vis Sci 48: 5742–5749

    Article  PubMed  Google Scholar 

  66. Spitzer MS, Yoeruek E, Kaczmarek RT, et al. (2008) Sodium hyaluronate gels as a drug-release system for corticosteroids: release kinetics and antiproliferative potential for glaucoma surgery. Acta Ophthalmol 86: 842–848

    Article  PubMed  CAS  Google Scholar 

  67. Driot JY, Novack GD, Rittenhouse KD, et al. (2004) Ocular pharmacokinetics of fluocinolone acetonide after Retisert Intravitreal implantation in rabbits over a 1-year period. J Ocul Pharm Th er 20: 269–275

    Article  CAS  Google Scholar 

  68. Jaffe GJ, Martin D, Callanan D, et al. (2006) Fluocinolone Acetonide Implant (Retisert) for Noninfectious Posterior Uveitis: Thirty-Four-Week Results of a Multicenter Randomized Clinical Study. Ophthalmol 113: 1020–1027

    Article  Google Scholar 

  69. Pearson P, Leavy B, Comstock T (2006) Fluocinolone Acetonide Implant Study Group. Fluocinolone acetonide intravitreal implant to treat diabetic macular edema: 3-year results of a multicenter clinical trial. Invest Ophthalmol Vis Sci 47: E-Abstract 5442

    Google Scholar 

  70. Hsu J (2007) Drug delivery methods for posterior segment disease. Current Opinion in Ophthalmology 18: 235–239

    Article  PubMed  Google Scholar 

  71. Galor A, Margolis R, Kaiser PK (2007) Lowder CY. Vitreous Band Formation and the Sustained-Release, Intravitreal Fluocinolone (Retisert) Implant. Arch Ophthalmol 125: 836–838

    Article  PubMed  Google Scholar 

  72. Ufret-Vincenty RL, Singh RP, Lowder CY, Kaiser PK (2007) Cytomegalovirus Retinitis After Fluocinolone Acetonide (Retisert(TM)) Implant. Am J Ophthalmol 143: 334–345

    Article  PubMed  Google Scholar 

  73. Taban MM, Lowder CYMDP, Kaiser PKM (2008) Outcome of fluocinolone acetonide implant Retisert(TM) reimplantation for chronic noninfectious posterior uveitis. Retina 28: 1280–1288

    Article  PubMed  Google Scholar 

  74. Whitcup SM, Csaky KG, Podgor MJ, et al. (1996) A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis. Ophthalmol 103: 1054–1062

    CAS  Google Scholar 

  75. Schilling H, Heiligenhaus A, Laube T, et al. (2005) Longterm effect of acetazolamide treatment of patients with uveitic chronic cystoid macular edema is limited by persisting inflammation. Retina 25: 182–188

    Article  PubMed  Google Scholar 

  76. Guex-Crosier Y, Othenin-Girard P, Herbort CP (1992) Traitement différencié de l’œdème maculaire cystoide inflammatoire postopératoire et secondaire aux uvéites. Klinische Monatsbläter Augenheilkunde 200: 367–367.

    Article  CAS  Google Scholar 

  77. Missotten T, van Laar JAM, van der Loos TL, et al. (2007) Octreotide Long-Acting Repeatable for the Treatment of Chronic Macular Edema in Uveitis. Am J Ophthalmol 144: 838–843

    Article  PubMed  CAS  Google Scholar 

  78. Papadaki T, Zacharopoulos I, Iaccheri B, et al. (2005) Somatostatin for Uveitic Cystoid Macular Edema (CME). Ocular Immunology & Inflammation 13: 469–470

    Article  CAS  Google Scholar 

  79. Kuijpers RWAM, Baarsma S, van Hagen PM (1998) Treatment of cystoid macular edema with octreotide. N Engl J Med 338: 624–626

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Retina and Inflammatory Diseases Unit, Center for specialized Ophthalmology, clinique de Montchoisi, Lausanne, Switzerland

    Marc D. de Smet

  2. Department of Ophthalmology, Ghent State University, Ghent, Belgium

    Marc D. de Smet

  3. Kyorin University, Tokyo, Japan

    Annabelle A. Okada

  4. Department of Ophthalmology, University of Amsterdam, Amsterdam, The Netherlands

    Marc D. de Smet

Authors
  1. Marc D. de Smet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Annabelle A. Okada
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag France, Paris

About this chapter

Cite this chapter

de Smet, M.D., Okada, A.A. (2011). Œdème maculaire cystoïde dans les uvéites. In: Œdèmes maculaires. Springer, Paris. https://doi.org/10.1007/978-2-8178-0118-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0118-6_8

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0117-9

  • Online ISBN: 978-2-8178-0118-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation